Literature DB >> 25274412

Molecular analysis of pbp2b in Streptococcus pneumonia isolated from clinical and normal flora samples.

J Sadeghi1, A Ahamadi, M Douraghi, M R Pourshafie, M Talebi.   

Abstract

Streptococcus pneumoniae is an important bacterial pathogen responsible for respiratory infections, bacteraemia, and meningitis remains an important cause of disease and mortality in infants and younger children around the world, with penicillin being considered the drug of choice for the treatment of infections. However, penicillin-resistant S. pneumonia is now becoming endemic worldwide. In this study, a total of 80 pneumococcal isolates were collected from different clinical sources as well as normal flora. These isolates were subjected to antimicrobial susceptibility testing and MIC determination. The penicillin-binding proteins, pbp2b, were amplified by PCR, and they were sequenced. The genetic relationship of the penicillin-resistant isolates was performed by BOX PCR. Overall, 36 pneumococcal (45 %) isolates were found to be resistant to penicillin with different MICs. The majority of them (80 %) were intermediately resistant with MIC of 0.12-1 µg/ml, whereas 20 % of isolates were penicillin resistant with MICs of >2 µg/ml. The results identified seven groups which were based on the amino acid substitutions of pbp2b. Sequencing analysis revealed that the most prevalent mutation was the substitution of Adenine for Thymine at the position 445 which is next to the second PBP2b-conserved motif (SSN). This study indicates that resistance to penicillin appears to be dependent on specific mutations in pbp2b, and the substitution in S620 → T near to the third PBP2b-conserved motif appears to be important in developing highly antibiotic-resistant isolates. Moreover, there was a positive correlation between the mutations in pbp2b gene and MIC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25274412     DOI: 10.1007/s00284-014-0704-7

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  28 in total

1.  Serotype distribution and antibiotic resistance of 140 pneumococcal isolates from pediatric patients with upper respiratory infections in Beijing, 2010.

Authors:  Lin Zhou; Sang-jie Yu; Wei Gao; Kai-hu Yao; A-dong Shen; Yong-hong Yang
Journal:  Vaccine       Date:  2011-08-10       Impact factor: 3.641

Review 2.  Mechanisms of antibiotic resistance and tolerance in Streptococcus pneumoniae.

Authors:  E Charpentier; E Tuomanen
Journal:  Microbes Infect       Date:  2000-12       Impact factor: 2.700

3.  Differential subsequence conservation of interspersed repetitive Streptococcus pneumoniae BOX elements in diverse bacteria.

Authors:  T Koeuth; J Versalovic; J R Lupski
Journal:  Genome Res       Date:  1995-11       Impact factor: 9.043

4.  PBP active site flexibility as the key mechanism for beta-lactam resistance in pneumococci.

Authors:  Carlos Contreras-Martel; Cécile Dahout-Gonzalez; Alexandre Dos Santos Martins; Miha Kotnik; Andréa Dessen
Journal:  J Mol Biol       Date:  2009-02-20       Impact factor: 5.469

5.  Analysis of penicillin-binding protein genes of clinical isolates of Streptococcus pneumoniae with reduced susceptibility to amoxicillin.

Authors:  Mignon du Plessis; Edouard Bingen; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

6.  Comparison of three different PCR-based methods to predict the penicillin nonsusceptible Streptococcus pneumoniae isolates from China.

Authors:  J-J Ding; X Su; F-M Guo; Y Shi; H-F Shao; X-Z Meng
Journal:  Lett Appl Microbiol       Date:  2008-12-02       Impact factor: 2.858

7.  Molecular epidemiology of penicillin-resistant and ciprofloxacin-resistant Streptococcus pneumoniae in Canada.

Authors:  Kimberly A Nichol; George G Zhanel; Daryl J Hoban
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

8.  Complete sequences of six penicillin-binding protein genes from 40 Streptococcus pneumoniae clinical isolates collected in Japan.

Authors:  Yumiko Sanbongi; Takashi Ida; Midori Ishikawa; Yumi Osaki; Hiroshi Kataoka; Takahisa Suzuki; Kumiko Kondo; Fukuichi Ohsawa; Minoru Yonezawa
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

9.  Penicillin susceptibility and epidemiological typing of invasive pneumococcal isolates in the Republic of Ireland.

Authors:  D Bennett; B Lennon; H Humphreys; M Cafferkey
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

10.  Compensatory evolution of pbp mutations restores the fitness cost imposed by β-lactam resistance in Streptococcus pneumoniae.

Authors:  Andrea G Albarracín Orio; Germán E Piñas; Paulo R Cortes; Melina B Cian; José Echenique
Journal:  PLoS Pathog       Date:  2011-02-17       Impact factor: 6.823

View more
  4 in total

1.  Determination of Characteristics of Erythromycin Resistant Streptococcus pneumoniae with Preferred PCV Usage in Iran.

Authors:  Malihe Talebi; Azadeh Azadegan; Javad Sadeghi; Ali Ahmadi; Mostafa Ghanei; Mohammad Katouli; Parviz Owlia; Mohammad R Pourshafie
Journal:  PLoS One       Date:  2016-12-29       Impact factor: 3.240

2.  Is Penicillin-Nonsusceptible Streptococcus pneumoniae a Significant Challenge to Healthcare System? A Systematic Review and Meta-Analysis.

Authors:  Farzad Khademi; Amirhossein Sahebkar
Journal:  Scientifica (Cairo)       Date:  2021-05-27

3.  Diversity of Mosaic pbp2x Families in Penicillin-Resistant Streptococcus pneumoniae from Iran and Romania.

Authors:  Seyed Fazlollah Mousavi; Marina Pana; Mohammad Feizabadi; Pantea Jalali; Maria Ghita; Dalia Denapaite; Regine Hakenbeck
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

4.  Serotype Distribution and Antibiotic Susceptibility of Streptococcus pneumoniae Isolates in Tehran, Iran: A Surveillance Study.

Authors:  Soheila Habibi Ghahfarokhi; Mehrdad Mosadegh; Ali Ahmadi; Mohammad Reza Pourmand; Mohammad Azarsa; Mohammad Rahbar; Bahram Nikmanesh
Journal:  Infect Drug Resist       Date:  2020-02-04       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.